Agamree Kit
Product Images NDC 69616-264
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Agamree (NDC 69616-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Catalyst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Aga01 0000 02)
Figure (Aga01 0000 03)
Figure (Aga01 0000 04)
Figure (Aga01 0000 05)
Figure (Aga01 0000 06)
Figure (Aga01 0000 07)
Figure (Aga01 0000 08)
Figure (Aga01 0000 09)
Figure (Aga01 0000 10)
Figure (Aga01 0000 11)
Figure (Aga01 0000 12)
Figure (Aga01 0000 13)
Figure (Aga01 0000 14)
Figure (Aga01 0000 15)
Principal Display Panel – 100 mL Carton Label (Aga01 0000 16)
Principal Display Panel – 100 mL Carton Label (Aga01 0000 17)
This text provides information about a medication called vamorolone, which is available in a 100 mL oral suspension. Each mL of the suspension contains 40 mg of vamorolone. The recommended dosage and administration instructions are not provided in the text, and it suggests referring to the prescribing information for more details. The medication should be stored at room temperature, between 68°F to 77°F (20°C to 25°C). Before each use, the bottle should be shaken well for 30 seconds. Once opened, the oral suspension should be tightly closed and kept refrigerated. Any unused oral suspension remaining after 3 months of opening the bottle should be discarded. The medication is manufactured in Italy for Catalyst Pharmaceuticals, Inc. located in Coral Gables, FL 33134.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.